Search by Drug Name or NDC
NDC 50419-0751-01 LAMPIT 120 mg/1 Details
LAMPIT 120 mg/1
LAMPIT is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals INC.. The primary component is NIFURTIMOX.
MedlinePlus Drug Summary
Nifurtimox is used to treat Chagas disease (an infection caused by a parasite) in children from birth to 18 years old who weigh at least 5.5 pounds (2.5 kg). Nifurtimox is in a class of medications called antiprotozoals. It works by killing the organism that can cause Chagas disease.
Related Packages: 50419-0751-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Nifurtimox
Product Information
| NDC | 50419-0751 |
|---|---|
| Product ID | 50419-751_379d893b-36ba-4d44-bb35-2eddbc49dfd3 |
| Associated GPIs | 16400055000340 |
| GCN Sequence Number | 039323 |
| GCN Sequence Number Description | nifurtimox TABLET 120 MG ORAL |
| HIC3 | W4K |
| HIC3 Description | ANTIPROTOZOAL DRUGS,MISCELLANEOUS |
| GCN | 95711 |
| HICL Sequence Number | 018218 |
| HICL Sequence Number Description | NIFURTIMOX |
| Brand/Generic | Brand |
| Proprietary Name | LAMPIT |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | nifurtimox |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 120 |
| Active Ingredient Units | mg/1 |
| Substance Name | NIFURTIMOX |
| Labeler Name | Bayer Healthcare Pharmaceuticals INC. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA213464 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50419-0751-01 (50419075101)
| NDC Package Code | 50419-751-01 |
|---|---|
| Billing NDC | 50419075101 |
| Package | 1 BOTTLE in 1 CARTON (50419-751-01) / 100 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2020-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |